News
The House and Senate will need to reconcile their versions of the bill for it to become law — something that has eluded the ...
Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...
Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the ...
22h
Investor's Business Daily on MSNTop-Performing Stock: CVS Health Raises Outlook After Strong Earnings BeatCVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.
Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
Pharmacology has been at it a long time. Precursor to the Western pill-based prescription for all that ails, it stands on the shoulders of a thousands-generations long compilation of the knowledge of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results